SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
This is to provide a focal point for those who follow this biotech stock.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
6136pbs.twimg.com ("rubraca" is the Agouron molecule)scaram(o)uche-11/8/2018
6135fda.gov PARP inhibitor for breast Ca with BRCA mutations.scaram(o)uche-1/12/2018
6134Anybody else watching PARP inhibitors role out FDA's door with chagrin?scaram(o)uche-3/27/2017
6133eximiaspharm.com <i>Oncology is the area of medicine that studies the causcaram(o)uche-4/14/2006
6132sorry for the horrendous formatting, from this week's (thanks R!) BioCenturyscaram(o)uche-12/5/2004
6131Message 19542898scaram(o)uche-11/28/2003
6130SARS back big time in Vancouver. Time to crank up the PIs.Henry Niman-8/17/2003
6129La Jolla researchers' aborted efforts to cure the common cold may yield a SAscaram(o)uche-8/11/2003
6128>> don't know what the references to news relate to << Peter isscaram(o)uche-5/13/2003
6127UPDATE - US panel backs Bristol-Myers anti-HIV drug Tuesday May 13, 7:31 pm ET scaram(o)uche-5/13/2003
6126don't know what the references to news relate to..... messages.yahoo.com mscaram(o)uche-5/13/2003
6125Phase III, 48-Week NEAT Study Results Comparing GW433908 (908) to Nelfinavir Prescaram(o)uche-2/14/2003
6124VIRACEPT(R) Studies Suggest No Apparent Increase in Birth Defects And Drug Levelscaram(o)uche-2/13/2003
612348-Week Resistance Data Comparing GW433908, Boosted and Unboosted, With Nelfinavscaram(o)uche-2/11/2003
6122Monday May 6, 6:49 pm Eastern Time Press Release SOURCE: PPD, Inc. PPD Discoveryscaram(o)uche-5/6/2002
6121Did anything emerge from AGPH-WL-PFE, except Viracept?Miljenko Zuanic-5/1/2002
6120Wednesday May 1, 10:45 am Eastern Time Press Release SOURCE: Pfizer Inc Californscaram(o)uche-5/1/2002
6119The Common Cold Meets Its Match Message 16819672sim1-12/21/2001
6118IMNR was my first short, one of very few ever (three?), in January 1992. Predicscaram(o)uche-8/30/2001
6117lots of old discussion -- in this thread -- relating to this project and its'scaram(o)uche-7/14/2001
6116Some old-timers might enjoy this? Emphasis mine........ Monday February 12, 8:scaram(o)uche-2/14/2001
6115Comments? Forgot why the lead compound was kicked-out, but it has attracted somkeokalani'nui-10/4/2000
6114Antiviral Res 2000 Sep 1;47(3):215-220 In vitro activityscaram(o)uche-9/21/2000
6113For old Agouron followers, AG3340 suffers a major setback: cbs.marketwatch.comtommysdad-8/4/2000
6112 Monday June 12, 7:30 am Eastern Time Company Press Release SOURCE: Isis Pharmscaram(o)uche-6/12/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News